Polyomaviruses of the skin: integrating molecular and clinical advances in an emerging class of viruses†
J.C. Sheu  J. Tran  P.L. Rady  H. Dao Jr  S.K. Tyring  H.P. Nguyen
First published: 26 December 2018 https://doi.org/10.1111/bjd.17592 Cited by: 1
†Funding sources None.
‡Conflicts of interest None to declare.
§J.C.S. and J.T. contributed equally to this work.
¶ Plain language summary available online
Read the full text
ePDFPDFTOOLS SHARE
Summary
Background
Human polyomaviruses (HPyVs) are small, nonenveloped, double‐stranded DNA viruses that express tumour antigen proteins. Fourteen species of polyomaviruses have been discovered in humans, and since the 2008 discovery of the first cutaneous polyomavirus – Merkel cell polyomavirus (MCPyV) – six more species have been detected in the skin: trichodysplasia spinulosa‐associated polyomavirus (TSPyV), HPyV6, HPyV7, HPyV9, HPyV10 and HPyV13. Of these cutaneous species, only MCPyV, TSPyV, HPyV6 and HPyV7 have been definitively associated with diseases of the skin, most commonly in immunocompromised individuals. MCPyV is a predominant aetiology in Merkel cell carcinomas. TSPyV is one of the aetiological factors of trichodysplasia spinulosa. HPyV6 and HPyV7 have been recently linked to pruritic skin eruptions. The roles of HPyV9, HPyV10 and HPyV13 in pathogenesis, if any, are still unknown, but their molecular features have provided some insight into their functional biology.

Results
In this review, we summarize the known molecular mechanisms, clinical presentation and targeted therapies of each of the eight cutaneous HPyVs.

Conclusions
We hope that heightened awareness and clinical recognition of HPyVs will lead to increased reports of HPyV‐associated diseases and, consequently, a more robust understanding of how to diagnose and treat these conditions.